Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | TLR4 | O00206 | 4/20 | 0.41 |
| ▸ | GJB2 | P29033 | 1/20 | 0.40 |
| ▸ | LY96 | Q9Y6Y9 | 3/20 | 0.40 |
| ▸ | TK2 | O00142 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15435989 | 1.00 | AKT1 (0.42) | AKT1TLR4GJB2LY96TK2 | |
| SCHEMBL15435985 | 1.00 | AKT1 (0.42) | AKT1TLR4GJB2LY96TK2 | |
| SCHEMBL11504137 | 1.00 | AKT1 (0.42) | AKT1TLR4GJB2LY96TK2 | |
| SCHEMBL7052046 | 0.95 | TLR4 (0.46) | TLR4 | |
| SCHEMBL15435982 | 0.92 | AKT1 (0.43) | AKT1 | |
| SCHEMBL15436002 | 0.92 | AKT1 (0.43) | AKT1 | |
| SCHEMBL4795989 | 0.92 | AKT1 (0.43) | AKT1 | |
| SCHEMBL10767543 | 0.92 | AKT1 (0.43) | AKT1 | |
| SCHEMBL758333 | 0.92 | AKT1 (0.43) | AKT1 | |
| SCHEMBL3025384 | 0.92 | AKT1 (0.43) | AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4093368-B1 | SKIN CARE COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12036302-B2 | Method of treating oxidative stress in skin and compositions therefor | THE PROCTER & GAMBLE COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| CN-115003274-B | Skin care composition | 宝洁公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-116997319-A | Stable skin care emulsions and methods of use thereof | 宝洁公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116981439-A | Methods of treating oxidative stress in skin and compositions thereof | 宝洁公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-4259084-A1 | STABLE SKIN CARE EMULSION AND METHODS OF USING THE SAME | The Procter & Gamble Company (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-4259083-A1 | METHOD OF TREATING OXIDATIVE STRESS IN SKIN AND COMPOSITIONS THEREFOR | The Procter & Gamble Company (US) | 2023-10-18 | — | — | EP | disclosed |
| US-20230108960-A1 | Skin Care Composition | PROCTER & GAMBLE (US) | 2023-04-06 | — | — | US | disclosed |
| US-11571379-B2 | Skin care composition | THE PROCTER & GAMBLE COMPANY (US) | 2023-02-07 | — | — | US | disclosed |
| EP-4093368-A1 | SKIN CARE COMPOSITION | The Procter & Gamble Company (US) | 2022-11-30 | — | — | EP | disclosed |
| CN-115003274-A | Skin care compositions | 宝洁公司 | 2022-09-02 | — | — | CN | disclosed |
| WO-2022132689-A1 | STABLE SKIN CARE EMULSION AND METHODS OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022132688-A1 | METHOD OF TREATING OXIDATIVE STRESS IN SKIN AND COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-23 | — | — | WO | disclosed |
| US-20220183936-A1 | Stable Skin Care Emulsion and Methods of Using the Same | THE PROCTER & GAMBLE COMPANY | 2022-06-16 | — | — | US | disclosed |
| US-20220183948-A1 | Method of Treating Oxidative Stress in Skin and Compositions Therefor | THE PROCTER & GAMBLE COMPANY | 2022-06-16 | — | — | US | disclosed |
| WO-2021150807-A1 | SKIN CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2021-07-29 | — | — | WO | disclosed |
| US-20210228469-A1 | Skin Care Composition | THE PROCTER & GAMBLE COMPANY | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220183936-A1 | Stable Skin Care Emulsion and Methods of Using the Same | SPTAN1, DEGS1, CUTA | AKT1 2164/4885TLR4 662/4885GJB2 4875/4885 |
| US-20210228469-A1 | Skin Care Composition | CUTA, RBP4, RBP1 | AKT1 4244/4885TLR4 1767/4885GJB2 3679/4885 |
| US-20220183948-A1 | Method of Treating Oxidative Stress in Skin and Compositions Therefor | HADHB, HADH, FAR1 | AKT1 736/4885TLR4 1507/4885GJB2 1504/4885 |
| US-20230108960-A1 | Skin Care Composition | CUTA, RBP4, RBP1 | AKT1 4244/4885TLR4 1767/4885GJB2 3679/4885 |
| US-12036302-B2 | Method of treating oxidative stress in skin and compositions therefor | HADHB, HADH, FAR1 | AKT1 736/4885TLR4 1507/4885GJB2 1504/4885 |
| US-11571379-B2 | Skin care composition | CUTA, RBP4, RBP1 | AKT1 4244/4885TLR4 1767/4885GJB2 3679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.